A highly significant difference in serum ANXA2 levels was found among 44 mostly HCV-positive Egyptian patients with HCC and CLD, as well as controls.
← all excerpts
Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
1
—
—